Discover Thomson Reuters
April 22 - Breakingviews columnists discuss the pharma M&A machine’s bid for its rival and activist investor Bill Ackman’s unusual role in backing the proposed deal.
02:54
02:28
00:46
01:41
00:44
01:02
01:50
00:28
01:59
01:36
02:25
01:05
01:47
02:36
02:21
02:10
01:17
01:14
00:51
03:08
01:21